Abstract:Background CD34 + cells have been used to treat the patients with heart failure, but the outcome is variable. It is of great significance to scrutinize the fate and the mechanism of CD34 + cell differentiation in vivo during heart failure and explore its intervention strategy. Methods We performed single-cell RNA sequencing (scRNA-seq) of the total non-cardiomyocytes and enriched Cd34-tdTomato + lineage cells in the murine (male Cd34-CreERT2; Rosa26-tdTomato mice) pressure overload model (transverse aortic constriction, TAC), and total non-cardiomyocytes from human adult hearts. Then, in order to determine the origin of CD34 + cell that plays a role in myocardial fibrosis, bone marrow transplantation model was performed. Furthermore, to further clarify the role of CD34 + cells in myocardial remodeling in response to TAC injury, we generated Cd34-CreERT2; Rosa26-eGFP-DTA (Cre/DTA) mice. Results By analyzing the transcriptomes of 59,505 single cells from the mouse heart and 22,537 single cells from the human heart, we illustrated the dynamics of cell landscape during the progression of heart hypertrophy, including CD34 + cells, fibroblasts, endothelial and immune cells. By combining genetic lineage tracing and bone marrow transplantation models, we demonstrated that non-bone-marrow-derived CD34 + cells give rise to fibroblasts and endothelial cells, while bone-marrow-derived CD34 + cell turned into immune cells only in response to pressure overload. Interestingly, partial depletion of CD34 + cells alleviated the severity of myocardial fibrosis with a significant improvement of cardiac function in Cd34-CreERT2; Rosa26-eGFP-DTA model. Similar changes of non-cardiomyocyte composition and cellular heterogeneity of heart failure were also observed in human patient with heart failure. Furthermore, immunostaining showed a double labeling of CD34 and fibroblast markers in human heart tissue. Mechanistically, our single-cell pseudotime analysis of scRNA-seq data and in vitro cell culture study revealed that Wnt-β-catenin and TGFβ1/Smad pathways are critical in regulating CD34 + cell differentiation toward fibroblasts. Conclusions Our study provides a cellular landscape of CD34 + cell-derived cells in the hypertrophy heart of human and animal models, indicating that non-bone-marrow-derived CD34 + cells differentiating into fibroblasts largely account for cardiac fibrosis. These findings may provide novel insights for the pathogenesis of cardiac fibrosis and have further potential therapeutic implications for the heart failure.

CD34+ Cell Atlas of Main Organs Implicates Its Impact on Fibrosis

Single Cell and Lineage Tracing Studies Reveal the Impact of CD34+ Cells on Myocardial Fibrosis During Heart Failure

Abstract 12723: Smooth Muscle-Derived CD34 + Cells after Vascular Injury Contribute to Vascular Remodeling

Altered lipid metabolism promoting cardiac fibrosis is mediated by CD34 + cell-derived FABP4 + fibroblasts

Nonbone Marrow CD34+Cells Are Crucial for Endothelial Repair of Injured Artery

CD36 and Its Role in Regulating the Tumor Microenvironment

Multilineage Contribution of CD34+ Cells in Cardiac Remodeling after Ischemia/reperfusion Injury.

Abstract 4140979: CD34 + Cells Contributed to Cardiac Fibrosis Are Regulated by Hyperlipidemia

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level

Single-cell transcriptomic profiling of heart reveals ANGPTL4 linking fibroblasts and angiogenesis in heart failure with preserved ejection fraction

Uncovering the Connection Between Ly6c Hi Cd103 + Myeloid Cells and Radiation-Induced Cardiac Fibrosis by Cytof

Single-Cell RNA-Sequencing Identifies Bone Marrow-Derived Progenitor Cells as a Main Source of Extracellular Matrix-Producing Cells Across Multiple Organ-Based Fibrotic Diseases

Dual genetic tracing reveals a unique fibroblast subpopulation modulating cardiac fibrosis

Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies

CD34+ Cell-Derived Fibroblast-Macrophage Cross-Talk Drives Limb Ischemia Recovery Through the OSM-ANGPTL Signaling Axis.

Host CD34+ cells are replacing donor endothelium of transplanted heart.

Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation

Abstract 2149: Smooth Muscle-derived Resident Vascular Adventitial Progenitor Cell Contribution To Cardiac Fibrosis And Inflammation Is Dependent On KLF4

The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease

Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy